Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, ZEPP HEALTH CORP reported revenue of $259M, up 41.8% year over year. Operating margin was -11.3% and net margin -15.5%, on a free-cash-flow margin of -10.1% with capital expenditure at 0.2% of revenue. Every figure is computed directly from ZEPP's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $259M | -11.3% | -15.5% |
| FY2024 | $183M | -25.9% | -41.5% |
| FY2023 | $353M | -8.6% | -8.8% |
| FY2022 | $614M | -10.1% | -7.0% |
| FY2021 | $981M | 1.5% | 2.2% |
How does ZEPP compare against its actual peer set?
The full CompsDesk Peer Benchmark Pack: up to 14 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, provenance for every number, board-ready PDF + CSV. One-off $249.
Related in the same sector: AAPL · ACA · ACMR · ACU · AGCO · AIMD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.